Results 81 to 90 of about 60,111 (283)

Increasing anaphylaxis events in Western Australia identified using four linked administrative datasets

World Allergy Organization Journal, 2020
Background: Anaphylaxis events are increasing worldwide, based on studies of single administrative datasets including hospital admissions, emergency room presentations, and prescription and medical claims data.
Sandra M. Salter, Ross J. Marriott, Kevin Murray, Samantha L. Stiles, Paul Bailey, Raymond J. Mullins, Frank M. Sanfilippo   +6 more
doaj  

The Features of Anaphylaxis Cases Followed in the Pediatric Allergy Clinic

Güncel Pediatri, 2017
Introduction: Anaphylaxis is a severe hypersensitivity reaction that can be life-threatening. The frequency of anaphylaxis varies among the societies.
Mahmut Doğru, İlknur Bostancı, Serap Özmen, Tayfur Giniş, Handan Duman Şenol   +4 more
doaj   +1 more source

THE PHYSIOLOGY OF THE IMMEDIATE REACTION OF ANAPHYLAXIS IN THE GUINEA-PIG [PDF]

, 1910
John Auer, Paul A. Lewis
openalex   +1 more source

Anaphylaxis [PDF]

BMJ, 2005
Sheikh, A., Walker, Samantha
openaire   +4 more sources

Amino Acid Stress Response Genes Contribute to a 25‐Fold Increased Risk of L‐Asparaginase–Induced Hypersensitivity

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background L‐asparaginase is essential in treating pediatric acute lymphoblastic leukemia (ALL) but is limited by hypersensitivity reactions in up to 70% of patients, leading to severe, dose‐limiting complications and compromised event‐free survival. Procedure This study conducted a genome‐wide association study (GWAS) in a discovery cohort of
Spencer J. Anderson, Erika N. Scott, Edward J. Raack, Wan‐Chun Chang, Miguel Córdova‐Delgado, Jessica N. Trueman, Catrina M. Loucks, S. Rod. Rassekh, Colin J. D. Ross, Bruce C. Carleton, the Canadian Pharmacogenomics Network for Drug Safety (CPNDS) consortium   +10 more
wiley   +1 more source

International consensus on (ICON) anaphylaxis

World Allergy Organization Journal, 2014
ICON: Anaphylaxis provides a unique perspective on the principal evidence-based anaphylaxis guidelines developed and published independently from 2010 through 2014 by four allergy/immunology organizations.
F. Estelle R. Simons, Ledit R.F. Ardusso, M Beatrice Bilò, Victoria Cardona, Motohiro Ebisawa, Yehia M. El-Gamal, Phil Lieberman, Richard F. Lockey, Antonella Muraro, Graham Roberts, Mario Sanchez-Borges, Aziz Sheikh, Lynette P. Shek, Dana V. Wallace, Margitta Worm   +14 more
doaj  

Missed Registration of Disease Codes for Pediatric Anaphylaxis at the Emergency Department

Emergency Medicine International, 2019
Background. It is important to register anaphylaxis codes correctly to study the exact prevalence of anaphylaxis. The purpose of this study was to analyze the clinical characteristics and disease codes of inaccurately registered groups in pediatric ...
Byungho Choi, Sun Hyu Kim, Hyeji Lee
doaj   +1 more source

The Perfusion Experiment in the Study of Anaphylaxis [PDF]

, 1919
Arthur F. Coca
openalex   +1 more source

EPINEPHRINE CONTENT OF THE SUPRARENAL GLANDS IN ANAPHYLAXIS [PDF]

, 1920
Maurice I. Smith, S. Ravitz
openalex   +1 more source

Using Pharmacokinetic and Pharmacodynamic Analysis to Optimize the Dosing Regimens of Fanastomig (EMB‐02) in Patients With Advanced Solid Tumors

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Fanastomig (also known as EMB‐02) is a bispecific antibody targeting programmed cell death protein‐1(PD‐1) and lymphocyte activation gene‐3 (LAG‐3), developed for the treatment of advanced solid tumors. A first‐in‐human (FIH) Phase I study (NCT04618393) evaluated safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD ...
Chengjun Jiang, Fang Ren, Mingfei Zhang, Qiaoyang Lu, Shuqi Zeng, Guang Yang, Yonghong Zhu   +6 more
wiley   +1 more source